Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Thürmann

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
The Clinical Investigator|January 1, 1992
Current concepts: converting enzyme inhibitors in coronary artery diseaseP Thürmann, N Rietbrock
Pharmacoeconomics|August 6, 1993
Determinants of hospital drug expenditures in Western EuropeP Thürmann, S Harder
International Journal of Clinical Pharmacology and Therapeutics|May 1, 1994
Economic aspects of drug therapy in hospitals: an issue for clinical pharmacologistsS Harder, P Thürmann
Blood Pressure. Supplement|January 1, 1994
Angiotensin-converting enzyme inhibition with spirapril in patients with coronary artery diseaseP Thürmann, N Rietbrock
Clinical Pharmacokinetics|June 1, 1996
Clinically important drug interactions with anticoagulants. An updateS Harder, P Thürmann
Deutsche Medizinische Wochenschrift (1946)|August 23, 1996
[Why is there no sustained-release form of captopril?]P Thürmann, N Rietbrock
Arzneimittel-Forschung|December 1, 1989
[The bioequivalence of two nifedipine fluid capsules]P Thürmann, N Bacracheva
Deutsche Medizinische Wochenschrift (1946)|September 16, 1988
[Angiotensin-converting enzyme inhibitors in angina pectoris]N Rietbrock, P Thürmann
Pharmacoeconomics|April 7, 1996
Criteria for the appropriate drug utilisation of immunoglobulinP Thürmann, S Harder
International Journal of Clinical Pharmacology, Therapy, and Toxicology|November 1, 1992
Concentration/effect analysis of antihypertensive drugs: single dose and steady state response to verapamilS Harder, P Thürmann
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
The Clinical Investigator|January 1, 1992
Current concepts: converting enzyme inhibitors in coronary artery diseaseP Thürmann, N Rietbrock
Pharmacoeconomics|August 6, 1993
Determinants of hospital drug expenditures in Western EuropeP Thürmann, S Harder
International Journal of Clinical Pharmacology and Therapeutics|May 1, 1994
Economic aspects of drug therapy in hospitals: an issue for clinical pharmacologistsS Harder, P Thürmann
Blood Pressure. Supplement|January 1, 1994
Angiotensin-converting enzyme inhibition with spirapril in patients with coronary artery diseaseP Thürmann, N Rietbrock
Clinical Pharmacokinetics|June 1, 1996
Clinically important drug interactions with anticoagulants. An updateS Harder, P Thürmann
Deutsche Medizinische Wochenschrift (1946)|August 23, 1996
[Why is there no sustained-release form of captopril?]P Thürmann, N Rietbrock
Arzneimittel-Forschung|December 1, 1989
[The bioequivalence of two nifedipine fluid capsules]P Thürmann, N Bacracheva
Deutsche Medizinische Wochenschrift (1946)|September 16, 1988
[Angiotensin-converting enzyme inhibitors in angina pectoris]N Rietbrock, P Thürmann
Pharmacoeconomics|April 7, 1996
Criteria for the appropriate drug utilisation of immunoglobulinP Thürmann, S Harder
International Journal of Clinical Pharmacology, Therapy, and Toxicology|November 1, 1992
Concentration/effect analysis of antihypertensive drugs: single dose and steady state response to verapamilS Harder, P Thürmann
Pageof 4